Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.
Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:PRN.
$7.63 -0.16 (-2.05%)
As of 06/24/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.